Skip to content

13F-HR filed by venBio Partners LLC

venBio Partners LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:15:25 UTC, with 9 holding rows worth $495,928,000.

Accession
0000905148-26-004927
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 9 entries on the cover page, a total value of $495,928,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $495,928,000 with VALUE read as dollars as filed, 13F file number 028-19529. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PARABILIS MEDICINES INC COM698955101Stock5,266,697$170,061,646dollars as filed
PHARVARIS NVN69605108COMMON STOCK4,458,977$141,438,750dollars as filed
ATTOVIA THERAPEUTICS INC04987L102COM4,181,366$71,668,613dollars as filed
ACHIEVE LIFE SCIENCES INC004468500COMMON STOCK5,914,720$47,850,085dollars as filed
ALUMIS INC022307102COM4,191,408$30,974,505dollars as filed
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK12,884,638$17,909,647dollars as filed
Yarrow Bioscience, Inc.92941V407Common Stock, $0.0001 par value554,769$12,493,398dollars as filed
LYELL IMMUNOPHARMA INC COM NEW55083R203Stock337,697$3,306,054dollars as filed
LISATA THERAPEUTICS INC128058302COM156,460$225,302dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000905148-26-004927this filing2026-11-16